Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its primary research programs are the investigation of optimal formulations of DehydraTECH-enhanced glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drugs as well as the investigation of cannabidiol (CBD) for the reduction of hypertension leading to a cleared IND application by the United States Food and Drug Administration. It operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 46 patents granted and many patents pending worldwide.


NDAQ:LEXX - Post by User

Bullboard Posts
Post by Oasis11on May 09, 2017 5:02pm
101 Views
Post# 26223012

Shorts Up By 76.41%

Shorts Up By 76.41%

Columbia Wanger Asset Management Has Raised Mb Financial (MBFI) Stake By $12.43 Million, LEXARIA BIOSCIENCE CORPORATION (LXRP) Shorts Up By 76.41%

May 9, 2017 - By Vivian Park

LEXARIA BIOSCIENCE CORPORATION (OTCMKTS:LXRP) had an increase of 76.41% in short interest. LXRP’s SI was 842,700 shares in May as released by FINRA. Its up 76.41% from 477,700 shares previously. With 314,000 avg volume, 3 days are for LEXARIA BIOSCIENCE CORPORATION (OTCMKTS:LXRP)’s short sellers to cover LXRP’s short positions. About 82,564 shares traded. Lexaria Bioscience Corp (OTCMKTS:LXRP) has risen 175.00% since September 30, 2016 and is uptrending. It has outperformed by 164.34% the S&P500.

https://www.mmahotstuff.com/2017/05/09/columbia-wanger-asset-management-has-raised-mb-financial-mbfi-stake-by-12-43-million-lexaria-bioscience-corporation-lxrp-shorts-up-by-76-41.html

Bullboard Posts